X

Trial Profile

Efficacy Study of COmbination of Edoxaban and Physiotherapy on PRevention and Thrombogenicity of Venous-Thromboembolism in patients after Total Knee Arthroplasty

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 13 Feb 2018

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Edoxaban (Primary)
Indications Venous thromboembolism
Focus Therapeutic Use
Acronyms ESCORT-TKA

Most Recent Events

16 Sep 2017 Primary endpoint has been met. (Differences in incidence rate of venous thromboembolism 7 days after opetration,and the changes in T-TAS parameters between edoxaban plus physiotherapy group and physiotherapy only group.) as per result published in the Circulation Journal
16 Sep 2017 Results published in the Circulation Journal
22 Jul 2017 Status changed from suspended to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com